Roche chairman likens US tariff policy to 'blackmail'

Roche’s chairman said U.S. tariff policies amount to "blackmail" and identified protectionism from both the U.S. and China as the company’s biggest geopolitical concern. The comments highlight ongoing trade-policy risk for a global pharmaceutical manufacturer with cross-border supply chains. The article is commentary rather than a direct earnings or guidance update, so immediate market impact should be limited.

Analysis

Roche’s chairman said U.S. tariff policies amount to "blackmail" and identified protectionism from both the U.S. and China as the company’s biggest geopolitical concern. The comments highlight ongoing trade-policy risk for a global pharmaceutical manufacturer with cross-border supply chains. The article is commentary rather than a direct earnings or guidance update, so immediate market impact should be limited.